4//SEC Filing
Egholm Michael 4
Accession 0000950170-25-076591
CIK 0001162194other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 8:03 PM ET
Size
7.0 KB
Accession
0000950170-25-076591
Insider Transaction Report
Form 4
Egholm Michael
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-05-21$1.03/sh−4,719$4,861→ 2,751,780 total - Tax Payment
Common Stock
2025-05-20$1.05/sh−18,343$19,260→ 2,756,499 total
Footnotes (3)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on May 21, 2024.
- [F2]The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the SEC on March 24, 2025.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Entity typeother
Related Parties
1- filerCIK 0001559779
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 8:03 PM ET
- Size
- 7.0 KB